Physician profile
Nima Mehran
NPI 1902126022
$31,206.25
in general payments reported to CMS, 2019-2025
14 companies · $16K in 2025
The $16K reported for 2025 was more than what 90% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $79.51 · 2021: $326 · 2022: $599 · 2023: $1,508 · 2024: $12K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $23K · Food and Beverage: $4,168 · Travel and Lodging: $3,296 · Gift: $30.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $22,707.34 |
| Food and Beverage | $4,168.10 |
| Travel and Lodging | $3,295.74 |
| Gift | $30.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $26,274.10 | 2024-2025 | Na |
| Stryker Corporation | $1,581.06 | 2020-2025 | Profyle, Mako, Variax |
| Saxum Surgical, INC. | $1,020.02 | 2023-2025 | |
| Depuy Synthes Sales INC. | $662.97 | 2022-2025 | Healix Knotless Peek, Rigidloop, Na |
| Curonix LLC | $423.26 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Smith+Nephew, INC. | $403.87 | 2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium, Q-Fix, N/A |
| Arthrex, INC. | $257.86 | 2023 | |
| Miach Orthopaedics, INC. | $207.80 | 2025 | |
| Vericel Corporation | $161.18 | 2025 | |
| Pacira Therapeutics, INC. | $59.94 | 2021 | |
| Catalyst Orthoscience | $51.04 | 2023 | Archer 3d Software, Csr & R1 Reverse Total Shoulder Systems, R1 Reverse Total Shoulder |
| Lilly USA, LLC | $46.83 | 2025 | Zepbound, Mounjaro |
| Deciphera Pharmaceuticals INC. | $30.27 | 2025 | Qinlock |
| Linvatec Corporation | $26.05 | 2025 | Biobrace 23mm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nima Mehran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.